For hair and skin, the evidence includes topical skin trials, wound studies, mouse hair-follicle data, and related copper-peptide hair follicle models rather than large, modern randomized trials for hair loss [2], [3], [6], [13]
research has examined NAD+ restoration in Alzheimers, Parkinsons, and Cockayne Syndrome models Metabolic disease studied in type 2 diabetes, obesity, and insulin resistance models for its role in glucose metabolism, lipid oxidation, and sirtuin-regulated insulin signalling Cardiovascular research SIRT1, SIRT3, SIRT6, and NAD+ have been studied for protective roles against dyslipidaemia, arrhythmia, cardiac fibrosis, hypertrophy, and ischemia-reperfusion injury Muscle and sarcopenia models NAD+ decline is linked to age-related muscle deterioration
Weeks 4 to 8: Improvements either plateau or persist
Cochrane Database of Systematic Reviews
If irritation develops, consult a physician